Meet our Students Button  

The Office of Admissions recruits and matriculates those individuals most likely to enhance the overall health of our local, regional, national and international communities through the development of new knowledge and the provision of exemplary patient care. Each year, the School of Medicine matriculates a group of talented individuals who reflect the growing ethnic and cultural diversity of present day society, drawing on the knowledge and skills of individuals from all segments of society. Learn more about our Vision & Values.

Through innovative identification, recruitment and development programs, the School of Medicine has become recognized for the rich diversity of its student body. The Committee on Admissions has the daunting yet important job of selecting an outstanding entering freshman class each year from a bright, dedicated and diverse pool of applicants. The Committee will admit only those individuals who demonstrate the intellectual curiosity necessary for a lifetime of learning and who the Committee believes will maintain the highest standards of ethical and professional conduct.

Our students are our most prized asset and our dedicated faculty takes great joy and pride in helping each and every one of them develop into our future colleagues in the profession of medicine.

  • 19 Medical School Deans Join Together to Call for Sustainable Biomedical Research Funding

    Unstable funding is threatening the viability of academic biomedical research in this country, according to a new paper published this week in the journal Science Translational Medicine. The paper was written jointly by the deans of 19 prominent medical schools around the country. Among this group is University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA.

  • University of Maryland School of Medicine Research Leads To FDA Approval of First Drug To Treat Radiation Sickness

    As a result of research performed by scientists at the University of Maryland School of Medicine (UM SOM), the U.S. Food and Drug Administration has approved the use of a drug to treat the deleterious effects of radiation exposure following a nuclear incident. The drug, Neupogen®, is the first ever approved for the treatment of acute radiation injury.

  • Q and A with world-renowned malaria research expert Dr. Chris Plowe

    Dr. Christopher Plowe is a world-renowned expert in malaria research. For more than 25 years, he has drawn support from NIH, including a long-standing Fogarty training grant to develop malaria research capacity in Mali. He founded and directs the University of Maryland School of Medicine's new Institute for Global Health, which will incorporate the school's Center for Malaria Research and Center for Vaccine Development.

  • So Long, Farewell, Class of 2015

    The Class of 2015 received their doctoral hoods in a special graduation ceremony at the Baltimore Convention Center on May 14. Hundreds of family, friends and faculty were there to cheer on the 157 graduates as they officially transitioned from students to doctors.

  • Annual Student Awards Ceremony Recognizes Top Graduates

    Following four years of late-night study groups, countless tests, and many cups of coffee, events leading up to graduation began with the ninth annual Student Awards Ceremony and Dinner, held on Wednesday, May 13, 2015 at the Southern Management Corporation Campus Center.

News Archive » Submit News » RSS
2015 Open House - June 3rd
Register Online

Download the Admissions Brochure